Preliminary Results of an On-Going Phase 1/2 Trial of Trimodality Therapy Using Hormonal Therapy, Radiation Therapy (RT), and Concurrent Docetaxel in Patients With High-Risk Pathologic T2-3N0M0 Prostate Cancer

✍ Scribed by Kumar, P.; Veldhuizen, P.; Thompson, M.; Shen, X.; Pinski, J.

• Book ID: 123056013
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 67 KB
• Volume: 87
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2013.06.1021